Riverside

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Macular degeneration2 trials

Phase

• Phase 21 trial
• Phase 31 trial

Status

• Active, not recruiting2 trials

Lead sponsor

• Adverum Biotechnologies, Inc.2 trials

Running trials

• Active, not recruiting

  Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-Related Macular Degeneration

  NCT06856577· Phase 3· Adverum Biotechnologies, Inc.· Source

• Active, not recruiting

  Safety and Efficacy of ADVM-022 in Treatment-Experienced Patients With Neovascular Age-related Macular Degeneration [LUNA]

  NCT05536973· Phase 2· Adverum Biotechnologies, Inc.· Source